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Purpose: To evaluate the morphological changes of the meibomian glands (MG) in patients with meibomian gland
dysfunction (MGD) compared to normal subjects by in vivo confocal microscopy and to investigate the relation of these
changes to the clinical ocular surface findings and tear functions.
Methods: Twenty MGD patients and 15 normal subjects were recruited into this prospective study. Patients and controls
underwent slit lamp examinations, tear film break-up time (BUT) measurements, fluorescein and Rose-Bengal stainings,
Schirmer test I without anesthesia, tear evaporation rate assessment (TEROS), tear film lipid layer interferometry (DR-1),
transillumination of the lids (meibography), MG expressibility test, and in vivo laser confocal microscopy of the lids
(HRTII-RCM).
Results: The BUT, DR-1 tear film lipid layer interferometry grades, fluorescein and Rose-Bengal staining scores, MG
drop out grade in meibography, and MG expressibility grades were significantly worse in MGD patients compared to
normal controls (p<0.05). The severity of both MG dropout and MG expressibility related significantly with the BUT,
DR-1 grades, and TEROS (p<0.05). The mean density of acinar units of MGs as measured by HRTII-RCM was
significantly lower in MGD patients (47.6±26.6/mm2) than in control subjects (101.3±33.8/mm2; p<0.05). The mean acinar
unit diameter as determined by HRTII-RCM was significantly larger in MGD patients (98.2±53.3 μm) than in controls
(41.6±11.9 μm; p<0.05). Both the density and diameter of MG acinar units related significantly with the severity of MG
dropout and MG expression grades (p<0.05).
Conclusions: In vivo confocal microscopy can effectively demonstrate the morphological changes of the MG in patients
with MGD. Glandular acinar density and acinar unit diameter seemed to be promising new parameters of in vivo confocal
microscopy, which is significantly related to the clinical ocular surface and tear function findings of MGD.
Meibomian glands (MG) are holocrine lipid excreting
glands embedded in the tarsal plate of the upper and lower
lids. Each MG comprises multiple acini connected by a long
common central duct running throughout the entire length of
the gland. Epithelial cells comprising the acini synthesize and
release lipids into the central ducts, which are then excreted
onto the ocular surface. Lipids excreted by MGs form the
superficial layer of the tear film and are thought to retard tear
evaporation and function as lubricants for the eyelids during
blinking [1].
Meibomian gland dysfunction (MGD) is a term that is
mainly used to describe obstructive MG disease. MGD is a
major cause of dry eyes and has been reported to result in the
alteration  and/or  reduction  of  lipid  secretions,  leading  to
increased tear evaporation, decreased tear stability, loss of
lubrication, and damage to the ocular surface epithelium [1].
MGD is one of the most common disorders encountered
in  ophthalmic  practices  [2].  Hom  et  al.  [3]  reported  the
prevalence of MGD to be 38.9%. Molinari and Stanek [4]
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found the prevalence to be 33% in patients younger than 30
years and 71.7% in individuals 60 years or older.
It is important to be able to classify and quantify MGD
for diagnostic reasons and to observe effects of treatment.
Several methods are available to assess MG status. Simple
clinical tests include grading the clinical features of MGD and
grading the expressibility and quality of the meibomian oil.
Expressibility of meibomian secretion can be performed with
digital eyelid pressure ab externo by slit lamp with assessment
placed on the viscosity or the clarity of the lipids expressed
[5-7].
One of the specialized methods is the measurement of oil
levels by meibometry, which involves blotting of lipids from
the  lower  central  lid  margin  onto  a  plastic  tape  [8-11].
Recently,  such  biomicroscopic  techniques  have  evolved
allowing for the in vivo imaging of the structure of MGs.
Meibography is one that involves transillumination of the MG
through the lids using an illuminated probe placed on the skin
along the length of the lid. The lid is everted, and the glandular
morphology can be photographed with or without the aid of
near infrared light [6,12,13]. The absence or dropout of glands
over the entire lid length is used as a quantitative measure of
gland loss.
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1263Confocal microscopy is a new emerging non-invasive
technology, which is useful as a supplementary diagnostic tool
for in vivo assessment of the histopathology of many ocular
surface diseases and anterior-segment disorders including the
in vivo examination of the bulbar and palpebral conjunctiva
and  the  MG  [14-20].  In  this  study,  we  used  confocal
microscopy, based on new diagnostic parameters, to evaluate
the morphological changes of the MG in patients with MGD
and  compared  the  results  with  those  of  healthy  control
subjects.  We  also  investigated  the  relation  of  these
morphological changes and parameters to the clinical ocular
surface findings and tear functions.
METHODS
Subjects and examinations: In this single center, prospective
clinical study, 40 eyes from 20 patients with MGD (MGD
group: 14 women and 6 men; Mean age: 65.9±15.5 years;
range: 30–99 years) and 30 eyes of 15 healthy control subjects
(Control group: 8 women and 7 men; Mean age: 56.8±13.6
years; range: 38–77 years) were recruited. None of the MGD
patients and the controls had a history of Sjögren syndrome,
Stevens-Johnson syndrome, chemical, thermal, and radiation
injury, or had undergone any ocular surgery or procedure that
would create an ocular surface problem. Subjects in this study
also did not have a history of systemic drug or contact lens
use. At ocular examination, particular attention was paid to
lids margins, tarsal and bulbar conjunctiva, and corneas. MGD
was assessed by careful slit lamp examination of the glandular
orifices,  mucocutaneous  junction  changes,  and  digital
expression of the meibomian lipids. All examinations were
performed  by  a  single  investigator  (Y.M.).  The  same
physician pressed gently on the upper and lower eyelids to
express the meibomian lipids. Meibum viscosity was graded
as described by Shimazaki et al. [6]. Only patients with simple
MGD who met all of the following criteria were included in
this study. The criteria for the diagnosis of simple MGD were
described as follows: 1) occluded MG orifices; 2) cloudy or
inspissated glandular secretion with lack of clear meibum
secretion  following  the  application  of  moderate  digital
pressure on the tarsus of the upper and lower eye lid; 3)
presence  of  keratinization  or  displacement  of  the
mucocutaneous  junction;  4)  absence  of  inflammatory  lid
disease  such  as  blepharitis  as  well  as  inflammatory  skin
disorders such as atopic dermatitis, seborrhea sicca, and acne
rosacea;  5)  absence  of  a  history  of  cicatricial  eyelid  and
conjunctival diseases such as trachoma, erythema multiforme,
ocular  cicatricial  pemphigoid,  and  chemical,  thermal,  or
radiation injury; and 6) absence of excessive meibomian lipid
secretion (seborrheic MGD). All subjects in this study gave
their informed consent. The examination procedures were
reviewed by the ethics board and approved at Keio University
School of Medicine.
Both eyes of each patient and control underwent tear film
lipid layer interferometry, tear evaporation rate measurements
from the ocular surface (TEROS), slit lamp examinations
including  tear  film  break-up  time  (BUT),  fluorescein  and
Rose-Bengal stainings of the ocular surface, Schirmer test І
without  anesthesia,  in  vivo  laser  confocal  microscopy,
transillumination  of  the  lids  with  a  transilluminator
(meibography), and the meibomian gland expressibility test
in this respective order.
Tear  evaporation  rate:  We  measured  the  TEROS  with  a
quartz  crystal  humidity  sensor  (Kao  Analytical  Research
Center,  Tochigi,  Japan)  [21,22].  The  temperature  and
humidity of the examination room were maintained at a range
from 20 °C to 25 °C and from 30% to 50%, respectively.
Tear film lipid layer interferometry: Tear film lipid layer
interferometry (DR-1; Kowa Co., Tokyo, Japan) was also
performed to evaluate the status of the tear film in all subjects.
DR-1  interferometry  observes  the  specular  reflected  light
from the tear surface [23,24]. The classification of tear lipid
layer patterns and gradings has been described previously
[23]. Briefly, the DR-1 images were classified from grade 1
to 5 as follows: Grade 1-somewhat gray color and uniform
distribution; Grade 2-somewhat gray color and non-uniform
distribution;  Grade  3-a  few  colors  and  non-uniform
distribution;  Grade  4-many  colors  and  non-uniform
distribution; and grade 5-corneal surface partially exposed
[23].
Tear film stability evaluation: The standard tear film BUT
measurement was performed after instillation of 2 µl of 1%
fluorescein preservative-free solution in the conjunctival sac
with a micropipette. The patients were instructed to blink
several times for a few seconds to ensure adequate mixing of
the dye. The interval between the last complete blink and
appearance of the first corneal black spot in the stained tear
film was measured three times, and the mean value of the
measurements was calculated. A BUT value of less than 5 s
was considered abnormal.
Tear quantity evaluation: For further evaluation of tears, the
standard  Schirmer  test  І  without  topical  anesthesia  was
performed.  The  sterilized  strips  of  filter  paper  (Showa
Yakuhin Kako Co. Ltd., Tokyo, Japan) were placed in the
lateral canthus away from the cornea and left in place for 5
min. Readings were recorded in millimeters (mm) of wetting
for 5 min. A value of less than 5 mm was considered abnormal.
Ocular  surface  examinations:  Preservative  free  solution
(2 μl) consisting of 1% fluorescein and 1% Rose-Bengal dye
were applied to the conjunctival sac with a micropipette as
described  before  [25].  The  Rose-Bengal  and  fluorescein
staining scores of the ocular surface ranged between 0 and 9
points. The van Bijsterveld scoring system was used for Rose-
Bengal staining. Briefly, the ocular surface was divided into
three  zones:  nasal  conjunctival,  corneal,  and  temporal
conjunctival areas. A staining score between 0 and 3 points
was employed in each zone with the minimum and maximum
total staining scores ranging between 0 and 9 points. The
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1264presence of scarce punctate staining received 1 point. The
presence  of  denser  staining  not  covering  the  entire  zone
received 2 points, and the presence of Rose-Bengal staining
over the entire zone received 3 points. In fluorescein staining,
the cornea was divided into three equal upper, middle, and
lower zones. Each zone had a staining score ranging between
0 and 3 points with the minimum and maximum total staining
scores ranging between 0 and 9 points. Likewise, the presence
of scarce staining in one zone was scored as 1 point whereas
punctate staining covering the entire zone was scored as 3
points.
Meibography: Transillumination examination (meibography)
was performed by using a transilluminator (Medicospot; MS-
H,  Neitz  Instruments  Co.  Ltd.,  Tokyo,  Japan).
Transillumination of the MG through the lids was achieved
by using an illuminated probe placed on the skin of the lower
eye lid, which was everted, and the glandular morphology
could be photographed along the entire length of the lower lid
by the slit lamp including nasal, temporal, and central lid
areas. This allowed quantification of the meibomian glandular
rows and their loss. Loss of visible MG structure (“gland
dropout”)  revealed  by  meibography  was  considered  as
evidence of obstructive MGD since this finding has been
reported  to  be  a  good  parameter  for  obstructive  MGD-
associated ocular surface disease [6,12,13]. The degree of MG
dropout was scored as described previously: Grade 0-no gland
dropout; Grade 1 dropout-loss of less than half of the glandular
structures; and Grade 2 dropout-loss of more than half of the
glandular structures [6,13].
Meibomian  gland  expressibility:  After  digital  pressure
application on the upper lid tarsus [5-7], the viscosity and
degree  of  meibum  expression  was  evaluated  semi-
quantitatively according to Shimazaki grading as follows:
Grade  0-clear  meibum  expressed  easily;  Grade  1-cloudy
meibum  expressed  with  mild  pressure;  Grade  2-cloudy
meibum expressed with more than moderate pressure; and
Grade  3-meibum  cannot  be  expressed  even  with  intense
pressure [6].
In vivo laser confocal microscopy: In vivo laser confocal
microscopy  was  performed  on  all  subjects  with  a  new
generation  confocal  microscope,  the  Rostock  Corneal
Software Version 1.2 of the HRTII-RCM (Heidelberg Retina
Tomograph  II-  Rostock  Cornea  Module,  Heidelberg
Engineering  GmbH,  Dossenheim,  Germany)  [17].  After
topical anesthesia with 0.4% oxybuprocaine, the subject’s
chin  was  placed  on  the  chin  rest.  The  objective  of  the
microscope  was  an  immersion  lens  covered  by  a
polymethylmethacrylate  cap  (Tomo-Cap;  Heidelberg
Engineering  GmbH,  Dossenheim,  Germany).  Comfort  gel
(Bausch&Lomb  GmbH,  Berlin,  Germany)  was  used  as  a
coupling agent between applanating lens cap and the eye lid.
After the eyelid was everted, the center of the Tomo-Cap was
applanated onto the palpebral conjunctiva by adjusting the
controller, and the digital images of the underlying MG could
be observed on the computer screen. When the first superficial
conjunctival  cells  were  visualized,  the  digital  micrometer
gauge was set at zero, and then by pressing on the foot pedal,
sequence images were recorded by a charge-coupled device
(CCD) color camera (maximum 30 frames/s) while gradually
moving the focal plane into the subconjunctival tissue until
the glandular structures were visualized. MGs were scanned
while  moving  the  applanating  lens  from  the  lids  margins
TABLE 1. COMPARISON OF AGE, GENDER, TEAR QUANTITY, TEAR STABILITY, LIPID LAYER INTERFEROMETRY, TEAR EVAPORATION RATE, VITAL
STAINING SCORES AND CLINICAL MEIBOMIAN GLAND STATUS BETWEEN NORMAL CONTROLS AND MGD PATIENTS.
Controls (n=15) MGDs (n=20) p value
Age (years) 56.8±13.6 65.9±15.5 p=0.074
Gender (% of female) 53.3 70.0 p=0.51
Schirmer test (mm) 12.7±9.6 9.3±7.2 p=0.11
BUT (s) 8.5±3.7 4.9±2.4 p=0.0001
DR-1 grading 2.3±0.8 3.6±0.8 p=0.0001
TEROS (10−7 g/cm2/s) 4.30±3.82 6.37±3.72 p=0.029
FS score (points) 0.5±0.9 2.4±2.8 p=0.0001
RB score (points) 0.2±0.6 1.1±1.7 p=0.0067
MG expressibility grading 0.3±0.5 2.2±0.9 p=0.0001
MG dropout grading 0.4±0.6 1.6±0.5 p=0.0001
Note the absence of significant age and sex differences between the controls and MGD patients. The Schirmer test value (tear
quantity)  was also not significantly different in MGD patients when compared to controls. Note that the mean tear stability
(BUT), DR-1 lipid layer interferometry grade, tear evaporation rate, vital staining scores (FS and RB scores), MG expressibility,
and drop out grades were significantly worse in patients with MGD when compared with controls. Data are given as mean±SD.
p values denote the statistical comparison between controls and MGDs. MG=meibomian gland, MGD=meibomian gland
dysfunction, BUT=tear film break-up time, TEROS=tear evaporation rate from ocular surface, DR-1=tear film lipid layer
interferometry, FS=fluorescein, RB=Rose Bengal.
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1265toward the fornix with minute vertical movements. MGs were
also scanned while moving the applanating lens along the
entire  lid  length  with  minute  horizontal  movements.  The
length of a single confocal microscopy examination session
was approximately 10 min. None of the subjects complained
of discomfort nor any adverse effect was observed after an
examination in this series.
The laser source employed in the HRTII-RCM was a
diode  laser  with  a  wavelength  of  670  nm.  The  two-
dimensional image sizes were 384x384 pixels with a 400x400
μm field of view. Optical resolution was 2 μm vertically and
4 μm horizontally, and the digital resolution was 1 μm/pixel
vertically and horizontally. The instrument also gave the focal
distance  of  the  image  obtained,  thereby  allowing  the
determination of the depth in microns. We devised two new
parameters, acinar unit diameter and density, to evaluate the
morphological changes in the MGs in this study. The acinar
unit diameter was measured with the internal software in
micrometers as the longest axis of the acinar unit according
to the protocol of this study. Clearly visible acinar units were
all counted in a 400x400 μm frame, and the acinar density was
described as the number of units/mm2. We calculated the mean
diameter and density of glandular acinar units from three
randomized non-overlapping high quality digital images of
the nasal, middle, and temporal lower eyelid (total of nine
images per eyelid).
Statistical analysis: All data are shown as the mean±standard
deviation (SD). The Mann–Whitney test was applied to test
the  statistical  differences  between  BUT,  Schirmer  test  І,
TEROS, the acinar unit diameter, and density of acinar units.
The Mann–Whitney U test was used to study the differences
between the fluorescein staining score, Rose-Bengal staining
score,  MG  dropout,  and  meibum  expression  grades.  Sex
differences between the groups were evaluated by using the
χ2 test. Inter-group differences were evaluated by using the
Figure 1. Relation of meibomian gland
(MG)  dropout  grades  with  tear
functions, ocular surface disorder, MG
acinar unit density and diameters. A-H:
The  MG  drop  out  grade  (severity)
showed significant relations with tear
functions  including  BUT,  DR-1  tear
film lipid layer interferometry grades,
TEROS,  and  fluorescein  and  Rose-
Bengal staining scores (p<0.05) except
the mean Schirmer test value (p>0.05;
A-F). Both the mean acinar unit density
and  diameter  showed  significant
relations  with  MG  drop  out  grades
(p<0.05; G-H).
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1266one-way  ANOVA  test.  The  differences  were  considered
statistically significant if the p values were less than 0.05.
RESULTS
There were no significant age and gender differences between
normal controls and MGD patients (p>0.05).
Tear  functions  and  ocular  surface  staining  scores:
Comparisons of tear functions, ocular surface findings, and
age and gender characteristics between normal controls and
MGD patients are shown in Table 1. The mean Schirmer test
value  was  not  significantly  different  in  normal  controls
(12.7±9.6 mm) when compared to the mean value in MGD
patients (9.3±7.2 mm; p>0.05).
The  BUT  values  were  significantly  lower  in  MGD
patients  (4.9±2.4  s)  when  compared  to  normal  controls
(8.5±3.7 s; p<0.05). Both the DR-1 interferometry grades and
the mean TEROS were significantly higher in MGD patients
when compared to controls (p<0.05). The mean fluorescein
and Rose-Bengal staining scores were significantly higher in
MGD  patients  (2.4±2.8,  1.1±1.7,  respectively)  when
compared with the controls (0.5±0.9, 0.2±0.6, respectively;
p<0.05).
MG drop out grades (meibography): None of the MGD
patients had grade 0 drop out changes in meibography. The
mean MG dropout grade as observed with meibography in
MGD patients was significantly higher compared to normal
controls (p<0.05) as shown in Table 1. The MG dropout grade
(severity)  showed  significant  relations  with  tear  functions
including  BUT,  DR-1  tear  film  lipid  layer  interferometry
grades, TEROS, fluorescein, and Rose-Bengal staining scores
(p<0.05) each except the mean Schirmer test value (p>0.05;
Figure 1A-F).
None of the MGD patients had grade 0 expressibility in
this  study.  The  mean  MG  expression  grade  was  also
significantly higher in MGD patients than in controls (p<0.05)
as shown in Table 1. The MG expressibility grade also showed
significant  relations  with  the  mean  BUT  values,  DR-1
interferometry grades, TEROS values, and fluorescein scores
Figure 2. Relation of meibomian gland
(MG)  expressibility  grades  with  tear
functions, ocular surface disorder, and
MG acinar unit density and diameters.
The  MG  expressibility  grade  also
showed  significant  relations  with  the
mean BUT values, DR-1 interferometry
grades, TEROS values and fluorescein
scores  (p<0.05)  except  the  mean
Schirmer test and Rose Bengal staining
scores (p>0.05; A-F). Both the density
and  diameter  of  acinar  units  were
significantly  related  with  the  MG
expressibility  grades  (p<0.05;  G  and
H).
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1267except  the  mean  Schirmer  test  and  Rose  Bengal  staining
scores (p>0.05; Figure 2A-F).
In  vivo  laser  confocal  microscopy  meibomian  gland
observations: The mean acinar unit density was 47.6±26.6/
mm2 in MGD patients. This value was significantly lower than
the mean value measured in normal controls (101.3±33.8/
mm2; p<0.05) as shown in Table 2. The mean acinar unit
diameter was significantly larger (98.2±53.3 µm) in MGD
patients than in controls (41.6±11.9 µm; p<0.05). Both the
mean acinar unit density and diameter showed significant
relations with MG dropout grades (p<0.05; Figure 1G-H).
Likewise, both the mean acinar unit density and diameter also
showed significant relations with MG expressibility grades
(p<0.05; Figure 2G-H). In vivo laser confocal microscopy
could effectively demonstrate the glandular acinar units in
healthy control subjects as shown in Figure 3A. In vivo laser
confocal microscopy images also disclosed morphological
alterations in patients with MGD including the enlargement
of  glandular  acinar  units  due  to  inspissation  of  meibum
secretions  (Figure  3B,C)  and  glandular  atrophy  with
periglandular fibrosis (Figure 3D).
DISCUSSION
MGs secrete lipids into the preocular tear film. These lipids
function as a barrier to the inward movement of skin surface
lipids,  make  the  eyelid  margin  hydrophobic,  reduce
evaporation  of  tears,  and  lubricate  the  ocular  surface  to
provide a clear optical image [13].
MGD is characterized by the inspissation of meibomian
lipids, resulting in hyposecretion of lipids into tears. MGD is
one  of  the  major  causes  of  ocular  discomfort  and
abnormalities of the ocular surface [1,13]. Reported ocular
surface and tear function abnormalities associated with MGD
include  an  increase  of  TEROS  and  osmolarity  of  tears,
damage  to  the  ocular  surface  epithelium  as  evidenced  by
increased  ocular  surface  vital  staining  scores,  decrease  in
conjunctival goblet cell density, increased MG drop out, and
decreased  meibum  expressibility  [1,26].  It  is  possible  to
evaluate the glandular function and ocular surface status in
MG disease by slit lamp observation of the morphological
changes  in  the  lid  margin  including  the  gland  secretion
expressibility, BUT measurements, lipid layer interferometry,
meibometry and biochemical lipid analyses, ocular surface
vital  stainings,  tear  evaporation  rate  measurements,  and
meibography [1,11].
In  accordance  with  previously  published  reports,  we
confirmed the presence of an ocular surface disease state,
which was characterized by shorter BUT, higher lipid layer
interferometry grades, TEROS, and higher ocular surface vital
staining  scores  in  our  MGD  patients  when  compared  to
healthy  control  subjects.  It  was  harder  to  express  the
meibomian secretions in the patients of the current series as
evidenced by the significantly higher expressibility grades.
Meibography  disclosed  a  significantly  higher  level  of
glandular drop out in our patients compared to controls. Eyes
with higher MG drop out grades had significantly worse tear
stability, higher tear film lipid layer interferometry grades
indicating lipid layer abnormality, higher TEROS and ocular
surface vital staining scores. Since glandular drop out may be
expected to be associated with lesser meibomian secretions
and  their  expressibility,  we  also  checked  the  meibum
expressibility as described by Shimazaki et al. [6] in a previous
report.  Similarly,  higher  grades  of  expressibility,  which
indicate comparably more advanced obstruction of the glands,
were associated with significantly worse tear stability, higher
tear evaporation, and ocular surface epithelial damage. These
findings reconfirmed the Shimazaki [6] report that ocular
surface and tear function disorders tended to be more severe
in eyes of patients with significant gland obstruction and MG
drop out.
To further investigate the morphological alterations in the
MGs, we employed in vivo laser confocal microscopy and
devised  two  new  confocal  microscopy  based  diagnostic
parameters,  glandular  acinar  unit  density  and  acinar  unit
diameter, for the first time in the literature, which we believed
might have had a relation with the morphological observations
of the MGs such as the MG drop out and MG expressibility
grades. To our surprise, eyes with higher MG drop out grades
in  meibography  had  significantly  lower  MG  acinar  unit
densities in confocal microscopy. Likewise, higher drop out
grades were associated with significant enlargement of acinar
unit diameter, which suggested inspissation of meibomian
secretions and inability of the glands to deliver lipids into the
tear film. Similarly, patients with higher MG expressibility
TABLE 2. COMPARISON OF ACINAR UNIT DENSITY AND DIAMETER OF MEIBOMIAN GLANDS IN NORMAL CONTROLS AND MGD PATIENTS.
Controls MGDs p value
Acinar unit density (/mm2) 101.3±33.8 47.6±26.6 p=0.0001
Acinar unit diameter (µm) 41.6±11.9 98.2±53.3 p=0.0001
Note that the mean acinar unit density was significantly lower in patients with MGD when compared with the control subjects.
The mean acinar unit diameter was significantly longer in MGD patients than in normal controls. Data are given as mean±SD.
p-values denote the statistical comparison between controls and MGDs. MG=meibomian gland, MGD=meibomian gland
dysfunction.
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1268Figure 3. Meibomian gland (MG) images observed by in vivo laser confocal microscopy. A: One of the MG images from a representative 45-
year-old male normal control subject is shown. White arrows depict a typical acinar unit. Note the presence of numerous and compact acinar
units. Mean acinar unit densities and diameters were calculated from a total of nine confocal images obtained from the lower lid of the subject.
The mean acinar unit density calculated was 112/mm2, and the mean acinar unit diameter was 46 μm. The diameter of the acinar unit depicted
by the arrows is 35 μm. B: One of the representative MG images from a 66-year-old female patient with MGD is shown. Note the enlargement
of acinar unit (outlined by white arrows) due to inspissation of meibum secretion. The MG drop out grade was 1, and expressibility grade was
1. Mean acinar unit densities and diameters were calculated from a total of nine confocal images obtained from the lower lid of the subject.
The mean acinar unit density calculated from the overall images was 69/mm2, and the acinar unit diameter was 72 μm. Note that acinar units
might show considerable enlargement. The diameter of the acinar unit depicted by the arrows is greater than 250 μm. C: One of the
representative MG images from a 54-year-old female patient with MGD is shown. The patient had advanced disease with grade 2 MGD and
the meibum secretion could not be expressed due to orifice obstruction (MG expressibility grade 2). Note the remarkable dilatation of acinar
units with inspissation of meibum secretions (white arrows). D: Representative MG image from a 78-year-old female patient with advanced
MGD is shown. The MG drop out grade was 2, and the MG expressibility grade was 3. Note the atrophy in the glands with extensive
periglandular fibrosis (white arrows).
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1269grades (i.e., patients in whom the MG secretions could not be
expressed  or  could  be  expressed  with  difficulty)  had
significantly lower acinar unit densities and longer acinar unit
diameters  in  confocal  microscopy.  Confocal  microscopy
could effectively demonstrate the build up of lipids in the
glands in patients with higher gland drop out or expressibility
grades as well as the engorgement and dilatation of acinar
units. We believe that these observations also explain the
previously reported histopathological changes in human MG
disease from meibomian glands obtained postmortem [27]. It
has been reported in humans and animal models of MGD that
hyperkeratinization  of  ductal  epithelium  results  in  the
shedding of keratinized material into the duct, which may lead
to obstruction of glandular orifices and a build up of glandular
secretions with a change in lipid composition [27-30]. The
changes in lipid composition have been reported to increase
the melting point, leading to an increase in lipid viscosity and
further inspissation of the glandular secretions [27]. These
events have been suggested to be followed by cystic dilatation
of  acini  and/or  ducts  [27,28].  The  pressure  from  the
accumulating  secretions  might  very  well  induce  acinar
atrophy. In this study, confocal microscopy disclosed similar
acinar  atrophy  changes  in  accordance  with  previous
histopathological  reports  [27].  The  atrophic  acinar  units
appeared  as  small  irregular  structures  with  periglandular
fibrosis  compared  to  normal  and  round  acini  observed  in
healthy control subjects.
Acinar  unit  density  and  diameter  seem  to  be  two
promising new confocal microscopy parameters, which we
believe will aid in the diagnosis and evaluation of MG disease.
Although statistically not significant, it should be noted that
the mean age in patients with MGD was higher than the
control subjects, which might have very likely affected the
results of this study. Recruitment of elderly control subjects
with normal gland morphology and functions is a challenging
issue due to the age related nature of MGD. Future studies on
age matched subjects would certainly eliminate such biases.
Future prospective studies on a larger number of patients and
healthy  controls  should  also  establish  the  sensitivity,
specificity, and cut-off values for these diagnostic parameters,
which  may  also  find  applications  in  the  assessment  of
treatment  outcomes  in  patients  with  MGD.  The  status  of
meibomian glands and changes of these parameters in MGD
associated with inflammatory lid disorders should be studied
in the future. Future confocal microscopy trials assessing the
effect of different treatment protocols on MGs would also
provide invaluable information.
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